ANIP Competitors & Alternatives

Compare ANI Pharmaceuticals Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

ANIP

Main Stock
$71.72
Tradestie Score
51
Market Cap
$2.01B
P/E Ratio
14.2
Revenue Growth
0.3%
Analyst Upside
+46.7%

Top Competitors

42 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
LQDA Liquidia Corporation Common Stock
$58.47
$1.90B 37.0 35 Compare
HROW Harrow, Inc. Common Stock
$28.60
$1.79B - 51 Compare
PAHC Phibro Animal Health Corporation Class A
$35.05
$1.65B 13.8 54 Compare
BCRX BioCryst Pharmaceuticals Inc
$7.67
$1.55B - 49 Compare
AMLX Amylyx Pharmaceuticals, Inc. Common Stock
$30.73
$1.49B - 39 Compare
AVDL Avadel Pharmaceuticals plc Ordinary Share
$21.64
$1.46B - 48 Compare
EVO Evotec SE American Depositary Shares
$1.68
$1.34B - 23 Compare
XERS Xeris Biopharma Holdings, Inc. Common Stock
$16.47
$1.29B - 38 Compare
AMPH Amphastar Pharmaceuticals, Inc.
$28.87
$1.25B 13.3 35 Compare
DVAX Dynavax Technologies Corporation
$15.50
$1.21B - 48 Compare

Data updated: Nov 12, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

42 stocks in this industry